| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human INO80 complex subunit E (INO80E) from ORIGENE TECHNOLOGIES | TP308292 | 20 ug | ORIGENE TECHNOLOGIES |
| Human inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (ITPA), transcript variant 1 from ORIGENE TECHNOLOGIES | TP720525 | 10 ug | ORIGENE TECHNOLOGIES |
| Human inner membrane protein, mitochondrial (IMMT), nuclear gene encoding mitochondrial protein, transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760022 | 50 ug | ORIGENE TECHNOLOGIES |
| Pip4k2a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513319 | 1 kit | ORIGENE TECHNOLOGIES |
| Pip5k1a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513322 | 1 kit | ORIGENE TECHNOLOGIES |
| PIP4K2A Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305243 | 10 ug | ORIGENE TECHNOLOGIES |
| PIP4K2B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418338 | 1 kit | ORIGENE TECHNOLOGIES |
| PIP5K1B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423713 | 1 kit | ORIGENE TECHNOLOGIES |
| Pip5k1b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513323 | 1 kit | ORIGENE TECHNOLOGIES |
| Pip4k2b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513320 | 1 kit | ORIGENE TECHNOLOGIES |
| PIP4K2B Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH318338 | 10 ug | ORIGENE TECHNOLOGIES |
| PIP5K1B Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH323713 | 10 ug | ORIGENE TECHNOLOGIES |
| PIP4K2C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405976 | 1 kit | ORIGENE TECHNOLOGIES |
| PIP5K1C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415828 | 1 kit | ORIGENE TECHNOLOGIES |
| Pip5k1c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513324 | 1 kit | ORIGENE TECHNOLOGIES |
| Pip4k2c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513321 | 1 kit | ORIGENE TECHNOLOGIES |
| PIP4K2C Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305976 | 10 ug | ORIGENE TECHNOLOGIES |
| PIP5K1C Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH315828 | 10 ug | ORIGENE TECHNOLOGIES |
| PIP5KL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407837 | 1 kit | ORIGENE TECHNOLOGIES |
| Pip5kl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513325 | 1 kit | ORIGENE TECHNOLOGIES |
| PIP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403135 | 1 kit | ORIGENE TECHNOLOGIES |
| Pip - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513318 | 1 kit | ORIGENE TECHNOLOGIES |
| PIP Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303135 | 10 ug | ORIGENE TECHNOLOGIES |
| PIPOX - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401274 | 1 kit | ORIGENE TECHNOLOGIES |
| Pipox - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513326 | 1 kit | ORIGENE TECHNOLOGIES |
| PIPOX Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301274 | 10 ug | ORIGENE TECHNOLOGIES |
| Pira1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513328 | 1 kit | ORIGENE TECHNOLOGIES |
| Pira11 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513329 | 1 kit | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated, serine-rich 2-like (SPATS2L), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414484 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 5-like 1 (SPATA5L1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411380 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated, serine-rich 2-like (SPATS2L), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420261 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated, serine-rich 1 (SPATS1) from ORIGENE TECHNOLOGIES | LY408087 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated, serine-rich 2-like (SPATS2L), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420262 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated, serine-rich 2 (SPATS2) from ORIGENE TECHNOLOGIES | LY411503 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 16 (SPATA16) from ORIGENE TECHNOLOGIES | LY403133 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 17 (SPATA17) from ORIGENE TECHNOLOGIES | LY408482 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 19 (SPATA19) from ORIGENE TECHNOLOGIES | LY406408 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 20 (SPATA20) from ORIGENE TECHNOLOGIES | LY411541 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 21 (SPATA21) from ORIGENE TECHNOLOGIES | LY404848 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 24 (SPATA24) from ORIGENE TECHNOLOGIES | LY430677 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 4 (SPATA4) from ORIGENE TECHNOLOGIES | LY408186 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 6 (SPATA6) from ORIGENE TECHNOLOGIES | LY412785 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 9 (SPATA9) from ORIGENE TECHNOLOGIES | LY410397 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 13 (SPATA13), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407201 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 2 (SPATA2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416911 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 2 (SPATA2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427705 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 22 (SPATA22), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410013 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 22 (SPATA22), transcript variant 3 from ORIGENE TECHNOLOGIES | LY432942 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 22 (SPATA22), transcript variant 6 from ORIGENE TECHNOLOGIES | LY432882 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 7 (SPATA7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421749 | 100 ug | ORIGENE TECHNOLOGIES |